POSC77 Incorporating Possibility of Cure into Cost Utility Analysis for Nivolumab in Adjuvant Treatment of Resected Stage III/IV Melanoma in France

التفاصيل البيبلوغرافية
العنوان: POSC77 Incorporating Possibility of Cure into Cost Utility Analysis for Nivolumab in Adjuvant Treatment of Resected Stage III/IV Melanoma in France
المؤلفون: G Harris, I Orsini, M Edmonson-Jones, A Moshyk, B Bregman, J Vanderpuye-Orgle, E Chowdhury, AF Gaudin, M Kurt
المصدر: Value in Health. 25:S101
بيانات النشر: Elsevier BV, 2022.
سنة النشر: 2022
مصطلحات موضوعية: Health Policy, Public Health, Environmental and Occupational Health
تدمد: 1098-3015
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::fa0bc13e8878fbac3128282d7f9e752f
https://doi.org/10.1016/j.jval.2021.11.482
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........fa0bc13e8878fbac3128282d7f9e752f
قاعدة البيانات: OpenAIRE